Search Results - "Friman, S"

Cholangiocarcinoma — Current Treatment Options by Friman, S.

“…The treatment for cholangiocarcinoma (CCA) remains a challenge because of the aggressive nature of the disease and the absence of effective treatments besides…”
Get full text

Recurrence of Disease After Liver Transplantation by Friman, S

“…Abstract Over the past decade, we have seen an increased number of patients living more than 20 years with their liver grafts. In turn, we are gaining more…”
Get full text

Polyomavirus BK Replication in De Novo Kidney Transplant Patients Receiving Tacrolimus or Cyclosporine: A Prospective, Randomized, Multicenter Study by Hirsch, H. H., Vincenti, F., Friman, S., Tuncer, M., Citterio, F., Wiecek, A., Scheuermann, E. H., Klinger, M., Russ, G., Pescovitz, M. D., Prestele, H.

“…Polyomavirus BK (BKV)‐associated nephropathy causes premature kidney transplant (KT) failure. BKV viruria and viremia are biomarkers of disease progression,…”
Get full text

Renal Function in De Novo Liver Transplant Recipients Receiving Different Prolonged‐Release Tacrolimus Regimens—The DIAMOND Study by TruneČka, P., Klempnauer, J., Bechstein, W. O., Pirenne, J., Friman, S., Zhao, A., Isoniemi, H., Rostaing, L., Settmacher, U., Mönch, C., Brown, M., Undre, N., Tisone, G.

“…DIAMOND: multicenter, 24‐week, randomized trial investigating the effect of different once‐daily, prolonged‐release tacrolimus dosing regimens on renal…”
Get full text

Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus by Vincenti, F., Friman, S., Scheuermann, E., Rostaing, L., Jenssen, T., Campistol, J. M., Uchida, K., Pescovitz, M. D., Marchetti, P., Tuncer, M., Citterio, F., Wiecek, A., Chadban, S., El‐Shahawy, M., Budde, K., Goto, N.

“…DIRECT (Diabetes Incidence after Renal Transplantation: Neoral C2 Monitoring Versus Tacrolimus) was a 6‐month, open‐label, randomized, multicenter study which…”
Get full text

Sotrastaurin, a Novel Small Molecule Inhibiting Protein‐Kinase C: Randomized Phase II Study in Renal Transplant Recipients by Friman, S., Arns, W., Nashan, B., Vincenti, F., Banas, B., Budde, K., Cibrik, D., Chan, L., Klempnauer, J., Mulgaonkar, S., Nicholson, M., Wahlberg, J., Wissing, K.‐M., Abrams, K., Witte, S., Woodle, E. S.

“…Sotrastaurin, a selective protein‐kinase‐C inhibitor, blocks early T‐cell activation through a calcineurin‐independent mechanism. In this study, de novo renal…”
Get full text

Successful Combined Partial Auxiliary Liver and Kidney Transplantation in Highly Sensitized Cross‐Match Positive Recipients by Olausson, M., Mjörnstedt, L., Nordén, G., Rydberg, L., Mölne, J., Bäckman, L., Friman, S.

“…Combined liver and renal transplantations can be performed against a positive cross‐match, indicating that the liver protects the kidney from the harmful HLA…”
Get full text

Excellent Liver Transplantation Survival and Prevention of Hepatitis B Recurrence Using Hepatitis B Immunoglobulin and Nucleoside or Nucleotide Analogue Along With Treating Physician Adherence to Treatment Protocol by Lindenger, C, Castedal, M, Cahlin, C, Friman, S

“…Abstract Introduction The introduction of hepatitis B immunoglobulin (HBIG) in the early 1990s dramatically reduced recurrence of hepatitis B after orthotopic…”
Get full text

Successful Treatment of Severe ABO Antibody-Mediated Rejection Using Bortezomib: A Case Report by Westphal, S, Hansson, S, Stelin, G, Holgersson, J, Mjörnstedt, L, Friman, S

“…Abstract Background Our program for ABO-incompatible renal transplantation includes antigen-specific immunoadsorption (extracorporeal columns with the A or B…”
Get full text

A Prospective, Randomized, Multicenter Trial of Tacrolimus‐Based Therapy with or without Basiliximab in Pediatric Renal Transplantation by Grenda, R., Watson, A., Vondrak, K., Webb, N. J. A., Beattie, J., Fitzpatrick, M., Saleem, M. A., Trompeter, R., Milford, D. V., Moghal, N. E., Hughes, D., Perner, F., Friman, S., Van Damme‐Lombaerts, R., Janssen, F.

“…In a 6‐month, multicenter, randomized, controlled, open‐label, parallel‐group trial, we investigated the efficacy and safety of adding basiliximab to a…”
Get full text

Pseudoaneurysm of the Hepatic Artery Following Liver Transplantation by Fistouris, J., Herlenius, G., Bäckman, L., Olausson, M., Rizell, M., Mjörnstedt, L., Friman, S.

“…We report 12 cases of pseudoaneurysm hepatic artery (PA) among 825 liver transplantations (OLT) performed between January 1985 and December 2005. In the early…”
Get full text

Long-Term Follow-up of Living Liver Donors by Castedal, M, Andersson, M, Polanska-Tamborek, D, Friman, S, Olausson, M, Fehrman-Ekholm, I

“…Abstract Objectives At our center living donor liver transplantation (LDLT) represents 4% of all transplantations. The aim of this cross-sectional study was to…”
Get full text

Conversion From Calcineurin Inhibitor to Either Mycophenolate Mofetil or Sirolimus Improves Renal Function in Liver Transplant Recipients With Chronic Kidney Disease: Results of a Prospective Randomized Trial by Herlenius, G, Felldin, M, Nordén, G, Olausson, M, Bäckman, L, Gustafsson, B, Friman, S

“…Abstract Background Chronic kidney disease (CKD) has emerged as a significant cause of morbidity and a risk factor for mortality after orthotopic liver…”
Get full text

What Are We Waiting For? Analyses of Factors Influencing Cold Ischemia Time by Wolfbrandt, A, Lindström, K, Mjörnstedt, L, Friman, S

“…Abstract Introduction Cold ischemia time (CIT) influences long-term graft survival after deceased donor (DD) kidney transplantation. The aim of the present…”
Get full text

Recurrence of Hepatitis C After Liver Transplantation by Friman, S.

“…Cirrhosis due to hepatitis C is currently the most common indication for liver transplantation in the United States as well as in Europe. The prognosis for…”
Get full text

Prognostic value of pre-transplant cardiomyopathy in Swedish liver transplanted patients for familial amyloidotic polyneuropathy by Okamoto, S., Wixner, J., Ericzon, B.-G., Friman, S., Lindqvist, P., Henein, M., Suhr, O. B.

“…Liver transplantation (LTx) for familial amyloidotic polyneuropathy (FAP) is a recognized treatment for halting disease progression. Since cardiac…”
Get full text

Extended right-sided liver resection for colorectal liver metastases—impact of percutaneous portal venous embolisation by Lindnér, P., Cahlin, C., Friman, S., Hafstrom, L., Klingenstierna, H., Lonn, L., Olausson, M., Rizell, M.

“…To compare the outcome after extended right liver lobe resection (ERL) for patients with liver metastases from colorectal cancer with preceding portal vein…”
Get full text

Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries by Brandsæter, B., Friman, S., Broomé, U., Isoniemi, H., Olausson, M., Bäckman, L., Hansen, B., Schrumpf, E., Oksanen, A., Ericzon, B.-G., Höckerstedt, K., Mäkisalo, H., Kirkegaard, P., Bjøro, K.

“…Background: Primary sclerosing cholangitis (PSC) is the most common indication for liver transplantation in the Nordic countries. Because these patients are…”
Get full text

Highly urgent liver transplantation: Possible impact of donor-recipient ABO matching on the outcome after transplantation by BØRO, K, ERICZON, B. G, FRIMAN, S, KIRKEGAARD, P, HÖCKERSTEDT, K, SÖDERDAHL, G, OLAUSSON, M, FOSS, A, SCHMIDT, L. E, ISONIEMI, H, BRANDSAETER, B

“…Survival after liver transplantation for fulminant hepatic failure has been reported to be less favorable than survival for patients with chronic liver…”
Get full text

Follow-up after Liver Transplantation for Primary Sclerosing Cholangitis: Effects on Survival, Quality of Life, and Colitis by SALDEEN, K, FRIMAN, S, OLAUSSON, M, OLSSON, R

“…Background: Except for primary biliary cirrhosis, primary sclerosing cholangitis (PSC) is now the commonest indication for liver transplantation in Sweden…”
Get full text